Dr. Reddy's Laboratories Ltd. ("Dr. Reddy's") is an Indian multinational pharmaceutical company.

According to the law firm press release, the lawsuit alleges Defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Dr. Reddy’s lacked an effective corporate quality system; and (2) as a result, Defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

On November 21, 2017, Lead Plaintiff and Counsel were appointed. Lead Plaintiff filed a consolidated Complaint on February 16, 2018. Lead Plaintiff filed an amended consolidated Complaint on March 5. Defendants filed a Motion to Dismiss the amended consolidated Complaint on May 9. On March 21, 2019, the Court issued an Order granting in part and denying in part Defendants' Motion to Dismiss.

On May 15, 2020, the parties entered into a Stipulation and Agreement of Settlement. The Court granted preliminary approval of the Settlement on May 18. On December 23, the Court granted final approval of the Settlement and entered Final Judgment.